LATS1 and colorectal carcinoma: Moreover, in vitro gain of function and loss of function tests revealed that silencing LATS1 dramatically increased the CRC cell's potential to proliferate and migrate, whereas LATS1 overexpression did the opposite, signifying the tumor-suppressive effects of LATS1.